濮阳东方看妇科技术好(濮阳东方看妇科技术值得信赖) (今日更新中)

Honored to have served @realDonaldTrump and the American people during these difficult times. pic.twitter.com/xT1hRoYBMh— Scott W. Atlas (@ScottWAtlas) December 1, 2020 176

Here comes the bride, right down the dollar aisle. A Miami couple took their passion for Target to a new level by taking their engagement photos at the store. 166

Hawaii may have a hurricane on its horizon next week -- though it's far too early to tell how close it will get.Hurricane Lane, a devastatingly strong Category 4 storm now, is heading west-northwest over the Pacific, and is forecast to weaken and pass south of the Aloha State around Wednesday.But the track is uncertain this early, and there's a chance Lane by Tuesday night could bring winds of at least tropical-storm strength (39 mph and higher) to Hawaii's Big Island, the Central Pacific Hurricane Center says.Early Saturday, the storm was more than 1,200 miles east-southeast of Hilo, Hawaii, with maximum sustained winds of 130 mph -- the lowest threshold for a Category 4.The storm could strengthen Saturday and Sunday, but it is expected to weaken to a Category 1 (sustained winds of 74-95 mph) by Tuesday or Wednesday, the National Hurricane Center says.Six computer forecast models predict Lane's center will pass south of Hawaii next week, but the outer bands still could bring strong winds to the islands if the center gets close enough.Lane's approach comes more than a week after Hawaii watched Hurricane Hector pass well to the south. 1159

Holidays will look different this year for many Americans, with dinners outside, social distancing, or passing on family gatherings altogether. But several companies developing rapid at-home COVID-19 tests are hopeful that won't be the case next year. The goal is to make inexpensive, easy-to-use COVID tests that can deliver results in minutes, just like a pregnancy test. "For people to feel comfortable to associate with friends or family, there needs to be a testing methodology ideally that can be performed at home," said Tony Lemmo, CEO of the manufacturing company BioDot.The company's technology is being used by over 70 manufacturers worldwide making COVID-19 antigen, antibody, and PCR tests. Their automated platforms dispense nanoliter/picoliter amounts of reagent onto the tests accurately and fast.Lemmo says just one of their systems can support the production of roughly 100 million COVID-19 tests per year, helping to make high-volume production possible.“We knew we were going to be called on by customers to manufacture more equipment to provide them the ability to manufacture more tests," said Lemmo. To meet customer demand, BioDot increased staffing and built a new facility, compressing production time from months to weeks. The FDA recently authorized the first rapid at-home test that can deliver results in 30 minutes, eliminating the need for a lab to test the sample. But the molecular single-use test will only be available to patients with a doctor's prescription who are suspected of being infected with COVID-19.Companies developing tests hope the FDA will soon authorize another at-home testing tool: the rapid antigen test.These inexpensive tests provide results within minutes, and companies developing them say millions could be sold without a doctor's referral.“From what we’re hearing, it’s really just a matter of possibly months before there’s at least sufficient data to be able to support an at-home use of a test like an antigen test," said Lemmo.Lemmo says if authorized by the FDA, manufacturers could make millions of these tests in a matter of months. But antigen tests are less accurate, and the FDA wants to ensure they'll be simple enough for people to use at home. There are also concerns over how the data will be reported to health authorities. “I think any at-home testing or massive rollout of a test into the communities needs to be done very carefully and with a lot of education around it," said Clinical Lab Director Melissa Miller. Dr. Miller is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill and Medical Director for the Clinical Microbiology Lab for the Medical Center.She worries the inaccuracies of these tests could eventually lead the public to lose trust in all testing. “Even at 98 percent specificity, which is very, very high. That means you’re going to have a false positive two out of every 100. If you started testing a hundred million people, this is millions of people who have a false-positive test," said Dr. Miller. She says this could lead to healthy people isolating and missing work or school unnecessarily, and false-negative results could give people a false sense of security. “These rapid antigen tests were pushed out to skilled nursing facilities; this is a very high-risk patient population. This is actually where you want a very accurate test," said Dr. Miller. She says it’s unclear how well antigen tests detect the virus in asymptomatic patients but agrees more data is needed to figure that out.“It might make more sense for K-12 schools, or even college settings, where there’s less risk for a poor outcome if you have a false positive or a false negative," said Dr. Miller. But with a growing demand for convenient at-home testing, manufacturers are hopeful that in the months ahead, the FDA will soon open the door to new solutions. 3889

Getting into an Ivy League or top ten university is typically extremely competitive and difficult, but the effects of the pandemic may be making it easier for some to now get into their dream school.Part of the reason for this is that enrollment is down at college campuses across the country.One poll, conducted by College Reaction and Axios, shows roughly 22 percent of college students have decided to take a gap year. That equates to about 4 million fewer college students enrolled this academic year.“Right now, colleges, as you have seen, they are desperate for tuition dollars,” said Christopher Rim, CEO of Command Education, a company that helps students get into competitive colleges. "Six out of 10 colleges want to fill their classes.”For months now, Rim has seen how the pandemic is making it much easier for students to get into some highly-competitive schools.“We had students who were waitlisted at top 10 and top 15 universities, and in a typical year, they would not have been getting in,” said Rim. “In June or July, they were getting offers of admissions, saying they are off the waitlist.”Rim says it’s because students have been deferring enrollment or taking a gap year.The gap-year trend and resulting reduced competition is also leading to a trend in college transfers. Rim’s company has had three to four times as many college students contact them this year, looking for help with a transfer.“We are having all of these transfer students reach out to us and say, ‘You know what? I want to transfer. This is the time to transfer. I’ll have the best shot. If my dream school was Georgetown or if my dream school was Yale, what do I need to do to stand out and get in because these schools also need students?’” said Rim.While current transfer students may have less competition, and thus, a better shot at getting into their preferred schools, high school seniors should prepare for this trend to reverse when they are applying for admissions in the fall of 2021.“For the current students right now, who are applying to colleges and they are seniors in high school, they are going to have the most difficult time,” said Rim. “Because all the students who took the gap year have taken those spots. Harvard has said 20 percent of their freshman incoming class has opted to take a gap year, which means Harvard is going to take 20 percent fewer freshmen.” 2385

来源：资阳报